Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08JYV
|
||||
| Former ID |
DIB016269
|
||||
| Drug Name |
PSMA subunit vaccine
|
||||
| Synonyms |
Recombinant soluble PSMA vaccine; RsPSMA vaccine; PSMA subunit vaccine (prostate cancer); PSMA recombinant soluble protein vaccine, CYTOGEN/Progenics; PSMA rs protein vaccine, CYTOGEN/Progenics; PSMA protein vaccine (prostate cancer), Progenics/CYTOGEN; PSMA purified protein vaccine (prostate cancer), Progenics/CYTOGEN; PSMA subunit vaccine (prostate cancer), Progenics/CYTOGEN; PSMA-based therapeutics, CYTOGEN/Progenics
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Phase 1 | [1] | ||
| Company |
Alphavax
|
||||
| Target and Pathway | |||||
| Target(s) | Glutamate carboxypeptidase II | Target Info | [2] | ||
| KEGG Pathway | Alanine, aspartate and glutamate metabolism | ||||
| Metabolic pathways | |||||
| Vitamin digestion and absorption | |||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| TNFalpha Signaling Pathway | |||||
| Reactome | Amino acid synthesis and interconversion (transamination) | ||||
| WikiPathways | One Carbon Metabolism | ||||
| References | |||||
| REF 1 | Clinical pipeline report, company report or official report of Alphavax. | ||||
| REF 2 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1606). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.